Alvogen’s Lotus Bags $50m Investment To Boost Access In Asia

Taiwan-Based Company Issues 17m New Shares

Lotus Pharmaceuticals aims to build a stronghold in Thailand and beyond, after the Alvogen subsidiary announced a partnership with a subsidiary of Thai state-owned conglomerate PTT, which includes a $50m capital injection.

Asia
"We believe the Southeast Asia region is a very attractive region," Lotus commented • Source: Shutterstock

More from Deals

More from Business